pocketful logo light
pocketful logo light
Samrat Pharmachem Ltd logo

Samrat Pharmachem Ltd

NSE: BSE: 530125

₹225.95

(0.67%)

Thu, 24 Sept 2026, 05:47 am

Samrat Pharmachem Shareholding

ShareholdersMAR 2026DEC 2025SEPT 2025JUN 2025MAR 2025
Promoters49.0949.0949.0949.0949.09
FII00000
DII0003.240
Public50.9150.9150.9147.6750.91
Government00000

Samrat Pharmachem Ltd Shareholding Pattern

The Samrat Pharmachem Ltd shareholding pattern provides detailed insights into how ownership of the company is distributed among promoters, FIIs, DIIs, public investors, and government entities. Tracking the Samrat Pharmachem Ltd shareholding structure helps investors understand institutional confidence, promoter commitment, and overall market sentiment.

Samrat Pharmachem Ltd (NSE: , BSE: 530125) operates in the Process industries sector and Chemicals: specialty industry. Monitoring the Samrat Pharmachem Ltd shareholding pattern regularly allows investors to analyze ownership trends and make informed investment decisions.

Samrat Pharmachem Ltd Shareholding Pattern (Latest)

The latest Samrat Pharmachem Ltd shareholding for Mar 2026 is:

  • Promoters: 49.09%
  • FII: 0%
  • DII: 0%
  • Public: 50.91%
  • Government: 0%

Promoter holding in Samrat Pharmachem Ltd remains stable, reflecting consistent long-term commitment.

Samrat Pharmachem Ltd Promoter Holding Trend

Promoter shareholding plays a crucial role in evaluating management confidence in Samrat Pharmachem Ltd.

  • Mar 2026: 49.09%
  • Dec 2025: 49.09%
  • Sept 2025: 49.09%
  • Jun 2025: 49.09%
  • Mar 2025: 49.09%

Promoter stake remains largely stable, showing consistent ownership structure.

Samrat Pharmachem Ltd FII Shareholding Trend

Foreign Institutional Investors (FIIs) reflect global investor sentiment toward Samrat Pharmachem Ltd.

  • Mar 2026: 0%
  • Dec 2025: 0%
  • Sept 2025: 0%
  • Jun 2025: 0%
  • Mar 2025: 0%

FII holding has declined, suggesting cautious sentiment among foreign investors.

Samrat Pharmachem Ltd DII Shareholding Trend

Domestic Institutional Investors (DIIs) include mutual funds, banks, and insurance companies.

  • Mar 2026: 0%
  • Dec 2025: 0%
  • Sept 2025: 0%
  • Jun 2025: 3.24%
  • Mar 2025: 0%

DII holdings remain stable, reflecting steady institutional participation.

Samrat Pharmachem Ltd Public Shareholding Trend

Public shareholding represents retail and non-institutional investors.

  • Mar 2026: 50.91%
  • Dec 2025: 50.91%
  • Sept 2025: 50.91%
  • Jun 2025: 47.67%
  • Mar 2025: 50.91%

Public holding remains stable with consistent retail participation.

Samrat Pharmachem Ltd Government Holding

Government holding in Samrat Pharmachem Ltd currently stands at 0%.

Samrat Pharmachem Ltd operates without significant government ownership.

Samrat Pharmachem Ltd Shareholding Analysis Summary

The Samrat Pharmachem Ltd shareholding pattern highlights the ownership structure and investor confidence in the company. Stable promoter holdings combined with institutional participation often indicate strong fundamentals and long-term growth potential.

Investors should monitor changes in Samrat Pharmachem Ltd shareholding for signals on institutional sentiment and ownership trends.

Regular monitoring of the Samrat Pharmachem Ltd shareholding helps investors understand market confidence, institutional activity, and potential future stock movements.

Open Your Free Demat Account

Enter your phone number